EICHORCondition: Type 1 Diabetes · Sponsor: Abbott Diabetes Care
This study will evaluate the occurrences of Diabetes-related Ketoacidosis (DKA) in adult and pediatric individuals living with Type I diabetes while managing diabetes with Abbott's Continuous Monitoring Systems.
This description comes directly from the study's public registry record.
Mohamed Nada Director, Clinical Affairs, PhD · 510-749-5416 · mohamed.nada@abbott.com
Always discuss trial participation with your own doctor first.
| Optimal Clinical Trials (North) | Rosedale, Auckland, New Zealand | — |
| New Zealand Clinical Research | Christchurch, Christchurch Central City, New Zealand | — |
| Health New Zealand-Southern | Dunedin, Otago, New Zealand | — |
| Optimal Clinical Trials | Auckland, New Zealand | — |
| Aotearoa Diabetes Collective | Hamilton, New Zealand | — |
| Te Pae Hauora o Ruahine o Tararua /MidCentral Health New Zealand | Palmerston North, New Zealand | — |
| New Zealand Clinical Research | Wellington, New Zealand | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07739342